- Home
- / SyneuRx International
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
SyneuRx International financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
NT$16.3
2024-01-26
Market Capitalization
NT$2.1 B
2024-01-26
Revenue
NT$5 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.3M | 5.0M | |||||
| Cost of goods sold | 270.0K | 1.1M | |||||
| Gross profit | 19.0K | 15.0K | 1.8M | 1.5M | 54.0K | 1.1M | 3.9M |
| Gross profit margin, % | 79.8% | 78.7% | |||||
| Operating expense total | 206.3M | 207.2M | 195.1M | 297.8M | 299.5M | 132.9M | 68.6M |
| Depreciation and amortization | 10.8M | 16.5M | 16.7M | 17.5M | 10.5M | 7.3M | 4.6M |
| EBITDA | (206.2M) | (207.2M) | (193.4M) | (296.3M) | (299.4M) | (131.9M) | (64.7M) |
| EBITDA margin, % | -9974.1% | -1301.9% | |||||
| EBIT | (218.4M) | (223.6M) | (210.1M) | (313.8M) | (310.4M) | (138.0M) | (69.3M) |
| EBIT margin, % | -10435.2% | -1394.2% | |||||
| Interest income | 5.6M | 4.0M | 2.8M | 813.0K | 583.0K | 822.0K | 582.0K |
| Interest expense | 250.0K | 122.0K | 472.0K | 670.0K | 532.0K | 229.0K | |
| Pre tax profit | (203.7M) | (224.3M) | (222.5M) | (315.3M) | (348.6M) | (136.5M) | (70.1M) |
| Income tax expense | 767.0K | (842.0K) | (3.2M) | (363.0K) | 5.9M | 60.0K | (214.0K) |
| Net Income | (204.4M) | (223.5M) | (219.3M) | (314.9M) | (354.5M) | (136.5M) | (69.9M) |